|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 4201 to 4300 out of 6467 for Myc

0.02s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Protein
Organism: Mus musculus/domesticus
Length: 293  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 642  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 207  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 536  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 168  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 541  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 207  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 648  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 91  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 310  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 641  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 355  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 511  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 296  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 330  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 169  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 94  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 216  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 222  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 638  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 917  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 166  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 641  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 310  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 610  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 591  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 649  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 199  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 179  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 370  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 160  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 231  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 263  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 489  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 324  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 64  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 209  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 199  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 477  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 223  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 507  
Fragment?: false
Publication
First Author: Krause M
Year: 1990
Journal: Cell
Title: CeMyoD accumulation defines the body wall muscle cell fate during C. elegans embryogenesis.
Volume: 63
Issue: 5
Pages: 907-19
Publication
First Author: Kato GJ
Year: 1992
Journal: FASEB J
Title: Function of the c-Myc oncoprotein.
Volume: 6
Issue: 12
Pages: 3065-72
Protein Domain
Type: Domain
Description: A number of eukaryotic proteins, which probably are sequence specific DNA-binding proteins that act as transcription factors, share a conserved domain of 40 to 50 amino acid residues. It has been proposed []that this domain is formed of two amphipathic helices joined by a variable length linker region that could form a loop. This 'helix-loop-helix' (HLH) domain mediates protein dimerization and has been found in the proteins listed below []. Most of these proteins have an extra basic region of about 15 amino acid residues that is adjacent to the HLH domain and specifically binds to DNA. They are referred as basic helix-loop-helix proteins (bHLH), and are classified in two groups: class A (ubiquitous) and class B (tissue-specific). Members of the bHLH family bind variations on the core sequence 'CANNTG', also referred to asthe E-box motif. The homo- or heterodimerization mediated by the HLH domain is independent of, but necessary for DNA binding, as two basic regions are required for DNA binding activity. The HLH proteins lacking the basic domain (Emc, Id) function as negative regulators, since they form heterodimers, but fail to bind DNA. The hairy-related proteins (hairy, E(spl), deadpan) also repress transcription although they can bind DNA. The proteins of this subfamily act together with co-repressor proteins, like groucho, through their -terminal motif WRPW.Proteins containing a HLH domain include:The myc family of cellular oncogenes [], which is currently known to contain four members: c-myc, N-myc, L-myc, and B-myc. The myc genes are thought to play a role in cellular differentiation and proliferation.Proteins involved in myogenesis (the induction of muscle cells). In mammals MyoD1 (Myf-3), myogenin (Myf-4), Myf-5, and Myf-6 (Mrf4 or herculin), in birds CMD1 (QMF-1), in Xenopus MyoD and MF25, in Caenorhabditis elegans CeMyoD, and in Drosophila nautilus (nau).Vertebrate proteins that bind specific DNA sequences ('E boxes') in various immunoglobulin chains enhancers: E2A or ITF-1 (E12/pan-2 and E47/pan-1), ITF-2 (tcf4), TFE3, and TFEB.Vertebrate neurogenic differentiation factor 1 that acts as differentiation factor during neurogenesis.Vertebrate MAX protein, a transcription regulator that forms a sequence- specific DNA-binding protein complex with myc or mad.Vertebrate Max Interacting Protein 1 (MXI1 protein) which acts as a transcriptional repressor and may antagonize myc transcriptional activity by competing for max.Proteins of the bHLH/PAS superfamily which are transcriptional activators. In mammals, AH receptor nuclear translocator (ARNT), single-minded homologues (SIM1 and SIM2), hypoxia-inducible factor 1 alpha (HIF1A), AH receptor (AHR), neuronal pas domain proteins (NPAS1 and NPAS2), endothelial pas domain protein 1 (EPAS1), mouse ARNT2, and human BMAL1. In Drosophila, single-minded (SIM), AH receptor nuclear translocator (ARNT), trachealess protein (TRH), and similar protein (SIMA).Mammalian transcription factors HES, which repress transcription by acting on two types of DNA sequences, the E box and the N box.Mammalian MAD protein (max dimerizer) which acts as transcriptional repressor and may antagonize myc transcriptional activity by competing for max.Mammalian Upstream Stimulatory Factor 1 and 2 (USF1 and USF2), which bind to a symmetrical DNA sequence that is found in a variety of viral and cellular promoters.Human lyl-1 protein; which is involved, by chromosomal translocation, in T- cell leukemia.Human transcription factor AP-4.Mouse helix-loop-helix proteins MATH-1 and MATH-2 which activate E box- dependent transcription in collaboration with E47.Mammalian stem cell protein (SCL) (also known as tal1), a protein which may play an important role in hemopoietic differentiation. SCL is involved, by chromosomal translocation, in stem-cell leukemia.Mammalian proteins Id1 to Id4 []. Id (inhibitor of DNA binding) proteins lack a basic DNA-binding domain but are able to form heterodimers with other HLH proteins, thereby inhibiting binding to DNA.Drosophila extra-macrochaetae (emc) protein, which participates in sensory organ patterning by antagonizing the neurogenic activity of the achaete- scute complex. Emc is the homologue of mammalian Id proteins.Human Sterol Regulatory Element Binding Protein 1 (SREBP-1), a transcriptional activator that binds to the sterol regulatory element 1 (SRE-1) found in the flanking region of the LDLR gene and in other genes.Drosophila achaete-scute (AS-C) complex proteins T3 (l'sc), T4 (scute), T5 (achaete) and T8 (asense). The AS-C proteins are involved in the determination of the neuronal precursors in the peripheral nervous system and the central nervous system.Mammalian homologues of achaete-scute proteins, the MASH-1 and MASH-2 proteins.Drosophila atonal protein (ato) which is involved in neurogenesis.
Publication
First Author: Galazo MJ
Year: 2016
Journal: Neuron
Title: Corticothalamic Projection Neuron Development beyond Subtype Specification: Fog2 and Intersectional Controls Regulate Intraclass Neuronal Diversity.
Volume: 91
Issue: 1
Pages: 90-106
Publication
First Author: Burbach KM
Year: 1992
Journal: Proc Natl Acad Sci U S A
Title: Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor.
Volume: 89
Issue: 17
Pages: 8185-9
Publication
First Author: Haupt Y
Year: 1992
Journal: Mol Biol Rep
Title: Nucleotide sequence of bup, an upstream gene in the bmi-1 proviral insertion locus.
Volume: 17
Issue: 1
Pages: 17-20
Publication
First Author: Bera TK
Year: 2004
Journal: Proc Natl Acad Sci U S A
Title: NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostate.
Volume: 101
Issue: 9
Pages: 3059-64
Publication
First Author: Numata A
Year: 2020
Journal: Blood
Title: Lysine acetyltransferase Tip60 is required for hematopoietic stem cell maintenance.
Volume: 136
Issue: 15
Pages: 1735-1747
Publication
First Author: Sanghvi VR
Year: 2019
Journal: Cell
Title: The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase.
Volume: 178
Issue: 4
Pages: 807-819.e21
Publication
First Author: Jadayel DM
Year: 1998
Journal: Gene
Title: The BCL7 gene family: deletion of BCL7B in Williams syndrome.
Volume: 224
Issue: 1-2
Pages: 35-44
Publication
First Author: Davis RL
Year: 1987
Journal: Cell
Title: Expression of a single transfected cDNA converts fibroblasts to myoblasts.
Volume: 51
Issue: 6
Pages: 987-1000
Publication
First Author: Maekawa M
Year: 2011
Journal: Nature
Title: Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1.
Volume: 474
Issue: 7350
Pages: 225-9
Publication
First Author: Sebastián C
Year: 2012
Journal: Cell
Title: The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism.
Volume: 151
Issue: 6
Pages: 1185-99
Publication
First Author: Kugel S
Year: 2016
Journal: Cell
Title: SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b.
Volume: 165
Issue: 6
Pages: 1401-1415
Publication
First Author: Pan D
Year: 2009
Journal: EMBO J
Title: SnoN functions as a tumour suppressor by inducing premature senescence.
Volume: 28
Issue: 22
Pages: 3500-13
Publication
First Author: Cho SH
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) family.
Volume: 108
Issue: 38
Pages: 15972-7
Publication
First Author: Freeman-Cook K
Year: 2021
Journal: Cancer Cell
Title: Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor.
Volume: 39
Issue: 10
Pages: 1404-1421.e11
Publication
First Author: Ribeiro D
Year: 2016
Journal: Cell Rep
Title: Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma Patients.
Volume: 16
Issue: 4
Pages: 979-993
Publication
First Author: Schmidt S
Year: 2019
Journal: Nat Cell Biol
Title: A MYC-GCN2-eIF2α negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer.
Volume: 21
Issue: 11
Pages: 1413-1424
Publication
First Author: Cunningham CA
Year: 2017
Journal: J Immunol
Title: Cutting Edge: Defective Aerobic Glycolysis Defines the Distinct Effector Function in Antigen-Activated CD8+ Recent Thymic Emigrants.
Volume: 198
Issue: 12
Pages: 4575-4580
Publication
First Author: Morfouace M
Year: 2014
Journal: Cancer Cell
Title: Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma.
Volume: 25
Issue: 4
Pages: 516-29
Publication
First Author: Pei Y
Year: 2012
Journal: Cancer Cell
Title: An animal model of MYC-driven medulloblastoma.
Volume: 21
Issue: 2
Pages: 155-67
Publication
First Author: Jahchan NS
Year: 2016
Journal: Cell Rep
Title: Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer.
Volume: 16
Issue: 3
Pages: 644-56
Publication
First Author: Rajbhandari N
Year: 2023
Journal: Cancer Cell
Title: Single-cell mapping identifies MSI(+) cells as a common origin for diverse subtypes of pancreatic cancer.
Volume: 41
Issue: 11
Pages: 1989-2005.e9
Publication
First Author: Pusapati RV
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: ATM promotes apoptosis and suppresses tumorigenesis in response to Myc.
Volume: 103
Issue: 5
Pages: 1446-51
Publication
First Author: Ischenko I
Year: 2021
Journal: Nat Commun
Title: KRAS drives immune evasion in a genetic model of pancreatic cancer.
Volume: 12
Issue: 1
Pages: 1482
Publication
First Author: Gerlach BD
Year: 2021
Journal: Cell Metab
Title: Efferocytosis induces macrophage proliferation to help resolve tissue injury.
Volume: 33
Issue: 12
Pages: 2445-2463.e8
Publication
First Author: ElShamy WM
Year: 1998
Journal: Neuron
Title: Growth arrest failure, G1 restriction point override, and S phase death of sensory precursor cells in the absence of neurotrophin-3.
Volume: 21
Issue: 5
Pages: 1003-15
Publication
First Author: Gu AD
Year: 2015
Journal: Immunity
Title: A critical role for transcription factor Smad4 in T cell function that is independent of transforming growth factor β receptor signaling.
Volume: 42
Issue: 1
Pages: 68-79
Publication
First Author: Newton RH
Year: 2018
Journal: Nat Immunol
Title: Maintenance of CD4 T cell fitness through regulation of Foxo1.
Volume: 19
Issue: 8
Pages: 838-848
Publication
First Author: Angelin A
Year: 2017
Journal: Cell Metab
Title: Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments.
Volume: 25
Issue: 6
Pages: 1282-1293.e7
Publication
First Author: Wotton S
Year: 2002
Journal: Cancer Res
Title: Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma.
Volume: 62
Issue: 24
Pages: 7181-5
Publication
First Author: Descargues P
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation.
Volume: 105
Issue: 7
Pages: 2487-92
Publication
First Author: Aibara D
Year: 2022
Journal: iScience
Title: Gene repression through epigenetic modulation by PPARA enhances hepatocellular proliferation.
Volume: 25
Issue: 5
Pages: 104196
Publication
First Author: Balasubramanian R
Year: 2021
Journal: Sci Adv
Title: Phase transition specified by a binary code patterns the vertebrate eye cup.
Volume: 7
Issue: 46
Pages: eabj9846
Publication
First Author: Vasilevsky NA
Year: 2011
Journal: Eur J Immunol
Title: OX40 engagement stabilizes Mxd4 and Mnt protein levels in antigen-stimulated T cells leading to an increase in cell survival.
Volume: 41
Issue: 4
Pages: 1024-34
Publication
First Author: Sommermann T
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis.
Volume: 117
Issue: 25
Pages: 14421-14432
Publication
First Author: Lolo FN
Year: 2017
Journal: Biol Open
Title: Elimination of classically-activated macrophages in tumor-conditioned medium by alternatively-activated macrophages.
Volume: 6
Issue: 12
Pages: 1897-1903
Publication
First Author: Ehrenreiter K
Year: 2009
Journal: Cancer Cell
Title: Raf-1 addiction in Ras-induced skin carcinogenesis.
Volume: 16
Issue: 2
Pages: 149-60
Publication
First Author: Kamijo T
Year: 1999
Journal: Cancer Res
Title: Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function.
Volume: 59
Issue: 10
Pages: 2464-9
Publication
First Author: Mori M
Year: 2014
Journal: Cell
Title: Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer.
Volume: 156
Issue: 5
Pages: 893-906
Publication
First Author: Nowak DG
Year: 2019
Journal: J Cell Biol
Title: The PHLPP2 phosphatase is a druggable driver of prostate cancer progression.
Volume: 218
Issue: 6
Pages: 1943-1957
Publication
First Author: Augert A
Year: 2020
Journal: Cancer Cell
Title: MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer.
Volume: 38
Issue: 1
Pages: 97-114.e7
Publication
First Author: Gardner EE
Year: 2024
Journal: Science
Title: Lineage-specific intolerance to oncogenic drivers restricts histological transformation.
Volume: 383
Issue: 6683
Pages: eadj1415
Publication
First Author: Sen T
Year: 2017
Journal: Cancer Res
Title: CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib.
Volume: 77
Issue: 14
Pages: 3870-3884
Publication
First Author: Kim DW
Year: 2016
Journal: Genes Dev
Title: Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer.
Volume: 30
Issue: 11
Pages: 1289-99
Publication    
First Author: Mathsyaraja H
Year: 2021
Journal: Elife
Title: Loss of MGA repression mediated by an atypical polycomb complex promotes tumor progression and invasiveness.
Volume: 10
Publication
First Author: Tanaka T
Year: 2017
Journal: J Exp Med
Title: Internal deletion of BCOR reveals a tumor suppressor function for BCOR in T lymphocyte malignancies.
Volume: 214
Issue: 10
Pages: 2901-2913
Publication
First Author: Antoszewski M
Year: 2022
Journal: Blood
Title: Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL.
Volume: 139
Issue: 16
Pages: 2483-2498
Publication
First Author: Vanden Bempt M
Year: 2018
Journal: Cancer Cell
Title: Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.
Volume: 34
Issue: 2
Pages: 271-285.e7
Publication
First Author: Wray J
Year: 2011
Journal: Nat Cell Biol
Title: Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation.
Volume: 13
Issue: 7
Pages: 838-45
Publication
First Author: Chen WS
Year: 2021
Journal: Cell Rep
Title: Single-cell transcriptomics reveals opposing roles of Shp2 in Myc-driven liver tumor cells and microenvironment.
Volume: 37
Issue: 6
Pages: 109974
Publication
First Author: Liu S
Year: 2022
Journal: Nat Commun
Title: Triiodothyronine (T3) promotes brown fat hyperplasia via thyroid hormone receptor α mediated adipocyte progenitor cell proliferation.
Volume: 13
Issue: 1
Pages: 3394
Publication
First Author: Weisberg SP
Year: 2014
Journal: Cell Rep
Title: ZFX controls propagation and prevents differentiation of acute T-lymphoblastic and myeloid leukemia.
Volume: 6
Issue: 3
Pages: 528-40
Publication
First Author: Unniraman S
Year: 2004
Journal: Nat Immunol
Title: Identification of an AID-independent pathway for chromosomal translocations between the Igh switch region and Myc.
Volume: 5
Issue: 11
Pages: 1117-23
Publication    
First Author: Miyamoto R
Year: 2021
Journal: Elife
Title: HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways.
Volume: 10
Publication
First Author: Knudsen KJ
Year: 2015
Journal: Genes Dev
Title: ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiation.
Volume: 29
Issue: 18
Pages: 1915-29
Publication
First Author: Cheng Y
Year: 2019
Journal: Cell Rep
Title: m6A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment.
Volume: 28
Issue: 7
Pages: 1703-1716.e6
Publication
First Author: Loizou JI
Year: 2009
Journal: J Immunol
Title: Histone acetyltransferase cofactor Trrap is essential for maintaining the hematopoietic stem/progenitor cell pool.
Volume: 183
Issue: 10
Pages: 6422-31